POTENTIAL ADVANTAGE OF REPAGLINIDE MONOTHERAPY IN GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND SEVERE RENAL IMPAIRMENT. - Mori, K.; Emoto, M.; Numaguchi, R.; Yamazaki, Y.; Urata, H.; Motoyama, K.; Morioka, T.; Shoji, T.; Inaba, M. (Acta Endocrinologica (1841-0987), 2017)